Clinical Trial Update: The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating how glycemic control and GLP-1 receptor agonism influence islet GLP-1 in people with type 1 and type 2 diabetes; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• GLP-1 receptor agonist

Snippet

Sponsor: Mayo Clinic | Conditions: Type 1 Diabetes, Type 2 Diabetes | Phase 2 | Status: RECRUITING